Replies to post #130550 on PharmaCyte Biotech Inc (PMCB)

[WallSt1]

That means IND could be file in August 2030 but no promise, it could be later lol

[$Pistol Pete$]

$PMCB If we are unable to successfully raise additional capital, our future clinical trials and product development could be limited and our long-term viability may be threatened.

We have experienced negative operating cash flows since our inception and have funded our operations primarily through sales of our equity securities. We will need to seek additional funds in the future through equity or debt financings, or strategic alliances with third parties, either alone or in combination with equity financings to complete our product development initiatives. These financings could result in substantial dilution to the holders of our common stock, or require contractual or other restrictions on our operations or on alternatives that may be available to us. If we raise additional funds by issuing debt securities, these debt securities could impose significant restrictions on our operations. Any such required financing may not be available in amounts or on terms acceptable to us, and the failure to procure such required financing could have a material and adverse effect on our business, financial condition and results of operations, or threaten our ability to continue as a going concern.

[NorthShoreTrading]

NICE!! “We anticipate that shortly after the filing of this Report we will file an Investigational New Drug Application (“IND”) with the United States Food and Drug Administration (“FDA”) to allow us to commence a human clinical trial involving LAPC although no assurance as to the timing can be given.”

[A2Z]

Thank you GodisGreat. Appreciate that. And yes I agree with you to on liking that paragraph. Let’s get er done next week then. I’m ready to eat some good ole crow. Come on KW I’m ready to eat crow and get this dog filed